Yuan Li

11PUBLICATIONS
2CO-AUTHORS
Molecular targetsPredictive and prognostic markersOncology and carcinogenesis not elsewhere classifiedSolid tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Apr 09, 2026
ITGB4 up-regulated by STAT3 reduces the sensitivity of bladder cancer to cisplatin by suppressing p53.

Zhuo Xing, Haozhe Xu, Pingxia Lin

|Apr 17, 2025
The prognostic value of CXCR4 PET/CT imaging in unilateral primary aldosteronism patients after adrenalectomy.

Shuai Shao, Haozhe Xu, Zhuo Xing

|Jul 06, 2024
Development and External Validation of Nomograms for Predicting Disease-Free Survival and Overall Survival in Patients with cT1-ccRCC After Partial Nephrectomy: A Multicenter Retrospective Study.

Haozhe Xu, Zhuo Xing, Jie Wang

|Feb 08, 2024
Gross Hematuria Does not Affect the Selection of Nephrectomy Types for Clinical Stage 1 Clear Cell Renal Cell Carcinoma: A Multicenter, Retrospective Cohort Study.

Zhuo Xing, Haozhe Xu, Kai Ai

|Jan 21, 2023
Bone Metastasis in Bladder Cancer.

Lei Yi, Kai Ai, Xurui Li

|Dec 22, 2022
Epigenetic Regulation in Urothelial Carcinoma.

Ke Li, Lin Qi, Guyu Tang

Pageof 2

Frequent Collaborators

1 joint publications

Haozhe Xu

1 joint publications

Yongbao Wei